Lena et al. (27) reported in EcoR Registry that the number of patients with increased cTnI or NT-proBNP was higher in patients with chemotherapy-induced cardiomyopathy than in patients without cardiotoxicity. The gene discussed is NPPB; the disease is cardiomyopathy.